FABP5 and Stroke: Collectively, these discoveries synergize with established targets such as ACSL4 and FABP5, to map a dynamic interplay of redox imbalance, metabolic dysregulation, and cell-type-specific vulnerability, thereby advancing therapeutic strategies for ferroptosis modulation in stroke.